415 related articles for article (PubMed ID: 17317197)
1. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy following bioprosthetic aortic valve replacement.
Nowell J; Wilton E; Markus H; Jahangiri M
Eur J Cardiothorac Surg; 2007 Apr; 31(4):578-85. PubMed ID: 17267235
[TBL] [Abstract][Full Text] [Related]
5. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
6. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.
Iung B; Rodés-Cabau J
Eur Heart J; 2014 Nov; 35(42):2942-9. PubMed ID: 25205532
[TBL] [Abstract][Full Text] [Related]
7. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
8. Should we anticoagulate after bioprosthetic aortic valve replacement?
Al-Atassi T; Toeg H; Ruel M
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1649-57. PubMed ID: 24215195
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
10. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK
J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results.
Colli A; Verhoye JP; Heijmen R; Strauch JT; Hyde JA; Pagano D; Antunes M; Koertke H; Ohri SK; Bail DH; Leprince P; Van Straten BH; Gherli T;
Eur J Cardiothorac Surg; 2008 Apr; 33(4):531-6. PubMed ID: 18203613
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation.
Carnicelli AP; O'Gara PT; Giugliano RP
Am J Cardiol; 2016 Nov; 118(9):1419-1426. PubMed ID: 27666180
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
14. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
15. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Bockeria LA; Skopin II; Kuts EV
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395
[No Abstract] [Full Text] [Related]
16. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
[TBL] [Abstract][Full Text] [Related]
17. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Miller MM; Hipp R; Matsumura ME
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1167-9. PubMed ID: 18669529
[TBL] [Abstract][Full Text] [Related]
18. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of thrombocyte aggregation after heart valve replacement].
von Schacky C
Z Kardiol; 1998; 87 Suppl 4():46-55. PubMed ID: 9857467
[TBL] [Abstract][Full Text] [Related]
20. Incidence of anticoagulation in patients with bioprostheses.
Gherli T; Colli A; Nicolini F
J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
